CoChat

Dexmedetomidine inhibits mitochondria damage and apoptosis of enteric glial cells in experimental intestinal ischemia/reperfusion injury via SIRT3-dependent PINK1/HDAC3/p53 pathway

Open access
Zhang, Qin, Liu, Xiao-Ming, Hu, Qian, Liu, Zheng-Ren, Liu, Zhi-Yi, Zhang, Huai-Gen, Huang, Yuan-Lu, Chen, Qiu-Hong, Wang, Wen-Xiang, Zhang, Xue-Kang · 2021 · Journal of Translational Medicine

The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.

Abstract

Background: Intestinal ischemia/reperfusion (I/R) injury commonly occurs during perioperative periods, resulting in high morbidity and mortality on a global scale. Dexmedetomidine (Dex) is a selective α2-agonist that is frequently applied during perioperative periods for its analgesia effect; however, its ability to provide protection against intestinal I/R injury and underlying molecular mechanisms remain unclear. Methods: To fill this gap, the protection of Dex against I/R injury was examined in a rat model of intestinal I/R injury and in an inflammation cell model, which was induced by tumor necrosis factor-alpha (TNF-α) plus interferon-gamma (IFN-γ) stimulation. Results: Our data demonstrated that Dex had protective effects against intestinal I/R injury in rats. Dex was also found to promote mitophagy and inhibit apoptosis of enteric glial cells (EGCs) in the inflammation cell model. PINK1 downregulated p53 expression by promoting the phosphorylation of HDAC3. Further studies revealed that Dex provided protection against experimentally induced intestinal I/R injury in rats, while enhancing mitophagy, and suppressing apoptosis of EGCs through SIRT3-mediated PINK1/HDAC3/p53 pathway in the inflammation cell model. Conclusion: Hence, these findings provide evidence supporting the protective effect of Dex against intestinal I/R injury and its underlying mechanism involving the SIRT3/PINK1/HDAC3/p53 axis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12967-021-03027-6

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Dex reduces oxidative stress and consequently alleviates intestinal I/R injury in rats. A Intestinal histopathological changes in rats. B Intestinal damage assessed by Chiu’s score. C Intestinal W/D ratio. D Level of MDA in intestinal tissues of rats. E SOD activity in intestinal tissues of rats. F Serum expression of TNF-α in rats. G Serum expression of IL-6 in rats. H The positive expression of GFAP and S-100β in the intestinal tissue of rats evaluated by IHC. I Western blot analysis for determination of protein expression of S-100β and GFAP in intestinal tissues of rats. J The apoptosis of EGCs in intestinal tissues of rats examined by TUNEL. *p < 0.05 vs. sham-operated rats; #p < 0.05 vs. rats with I/R injury; &p < 0.05 vs. rats with Dex1 (2.5 μg/(kg/h) Dex) treatment. Measurement data were expressed as mean ± standard deviation. Comparison among multiple groups was conducted by one-way ANOVA with Tukey’s post hoc test. N = 10
Fig. 1 Dex reduces oxidative stress and consequently alleviates intestinal I/R injury in rats. A Intestinal histopathological changes in rats. B Intestinal damage assessed by Chiu’s score. C Intestinal W/D ratio. D Level of MDA in intestinal tissues of rats. E SOD activity in intestinal tissues of rats. F Serum expression of TNF-α in rats. G Serum expression of IL-6 in rats. H The positive expression of GFAP and S-100β in the intestinal tissue of rats evaluated by IHC. I Western blot analysis for determination of protein expression of S-100β and GFAP in intestinal tissues of rats. J The apoptosis of EGCs in intestinal tissues of rats examined by TUNEL. *p < 0.05 vs. sham-operated rats; #p < 0.05 vs. rats with I/R injury; &p < 0.05 vs. rats with Dex1 (2.5 μg/(kg/h) Dex) treatment. Measurement data were expressed as mean ± standard deviation. Comparison among multiple groups was conducted by one-way ANOVA with Tukey’s post hoc test. N = 10CC BY · PubMed Central
Fig. 2 Dex reduces TNF-α- and IFN-γ-stimulated mitochondrial damage and apoptosis of EGCs. A Assessment of apoptosis by Annexin-V/PI in EGCs after 48 h of Dex treatment examined by flow cytometry. Cells were considered to be in early apoptosis, that was stained with Annexin-V but not with PI (Annexin-V+/PI−), and cells that were stained with both (Annexin-V+/PI+) were considered to be necrotic or late apoptotic. Cells that were stained with PI alone or (Annexin-V−/PI+) were necrotic. At least 10,000 cells for each sample were analyzed in each experiment. B The changes of EGCs morphology observed by Hoechst 33,258 staining. C Detection of MMP in EGCs. D LC3-II/I ratio and protein expression of Atg5, p62, Bax, Bcl-2, caspase-3, and cleaved caspase-3 in the EGCs measured by Western blot analysis. *p < 0.05 vs. EGCs without any treatment; #p < 0.05 vs. EGCs treated with 50 ng/mL of TNF-α, 100 ng/mL of IFN-γ; &p < 0.05 vs. Dex group (EGCs treated with 50 ng/mL of TNF-α, 100 ng/mL of IFN-γ and 1 μM of Dex). Measurement data were expressed as mean ± standard deviation. Comparison among multiple groups was conducted by one-way ANOVA with Tukey’s post hoc test. The cell experiment was repeated three times
Fig. 2 Dex reduces TNF-α- and IFN-γ-stimulated mitochondrial damage and apoptosis of EGCs. A Assessment of apoptosis by Annexin-V/PI in EGCs after 48 h of Dex treatment examined by flow cytometry. Cells were considered to be in early apoptosis, that was stained with Annexin-V but not with PI (Annexin-V+/PI−), and cells that were stained with both (Annexin-V+/PI+) were considered to be necrotic or late apoptotic. Cells that were stained with PI alone or (Annexin-V−/PI+) were necrotic. At least 10,000 cells for each sample were analyzed in each experiment. B The changes of EGCs morphology observed by Hoechst 33,258 staining. C Detection of MMP in EGCs. D LC3-II/I ratio and protein expression of Atg5, p62, Bax, Bcl-2, caspase-3, and cleaved caspase-3 in the EGCs measured by Western blot analysis. *p < 0.05 vs. EGCs without any treatment; #p < 0.05 vs. EGCs treated with 50 ng/mL of TNF-α, 100 ng/mL of IFN-γ; &p < 0.05 vs. Dex group (EGCs treated with 50 ng/mL of TNF-α, 100 ng/mL of IFN-γ and 1 μM of Dex). Measurement data were expressed as mean ± standard deviation. Comparison among multiple groups was conducted by one-way ANOVA with Tukey’s post hoc test. The cell experiment was repeated three timesCC BY · PubMed Central
Fig. 3 Dex restrains TNF-α- and IFN-γ-stimulated mitochondrial damage and apoptosis in EGCs through the SIRT3-mediated PINK1-related pathway. A Detection of MMP changes in EGCs. B The apoptosis of EGCs examined by flow cytometry. C Protein expression of SIRT3, PINK1, Bax, Bcl-2, Atg5, p62, p53, caspase-3, and cleaved caspase-3 along with LC3-II/I ratio in the EGCs measured by Western blot analysis. *p < 0.05 vs. the Mod group (EGCs treated with 50 ng/mL of TNF-α and 100 ng/mL of IFN-γ); #p < 0.05 vs. EGCs treated with 50 ng/mL of TNF-α, 100 ng/mL of IFN-γ and 1 μM of Dex. Measurement data were expressed as mean ± standard deviation. Comparison among multiple groups was conducted by one-way ANOVA with Tukey’s post hoc test. The cell experiment was repeated three times
Fig. 3 Dex restrains TNF-α- and IFN-γ-stimulated mitochondrial damage and apoptosis in EGCs through the SIRT3-mediated PINK1-related pathway. A Detection of MMP changes in EGCs. B The apoptosis of EGCs examined by flow cytometry. C Protein expression of SIRT3, PINK1, Bax, Bcl-2, Atg5, p62, p53, caspase-3, and cleaved caspase-3 along with LC3-II/I ratio in the EGCs measured by Western blot analysis. *p < 0.05 vs. the Mod group (EGCs treated with 50 ng/mL of TNF-α and 100 ng/mL of IFN-γ); #p < 0.05 vs. EGCs treated with 50 ng/mL of TNF-α, 100 ng/mL of IFN-γ and 1 μM of Dex. Measurement data were expressed as mean ± standard deviation. Comparison among multiple groups was conducted by one-way ANOVA with Tukey’s post hoc test. The cell experiment was repeated three timesCC BY · PubMed Central
Fig. 4 PINK1 reduces p53 expression by promoting the phosphorylation of HDAC3. A Binding between HDAC3 and p53 in EGCs verified by Co-IP. B HDAC3 phosphorylation level and protein expression of PINK1, HDAC3, and p53 in EGCs transfected with sh-PINK1 determined by Western blot analysis. C Interaction among PINK1, HDAC3, and p53 in EGCs transfected with sh-PINK1 identified by Co-IP. D Western blot analysis for determination of protein expression of HDAC3 and p53 in EGCs with RGFP966 treatment. E The acetylation level of p53 assessed by Co-IP. F Binding between HDAC3 and PINK1 in EGCs verified by Co-IP. G HDAC3 phosphorylation level and protein expression of PINK1, HDAC3, and p53 in EGCs transfected with sh-PINK1 measured through Western blot analysis. *p < 0.05 vs. EGCs transfected with sh-NC, EGCs treated with 50 ng/mL of TNF-α and 100 ng/mL of IFN-γ) or TNF-α and IFN-γ -exposed EGCs transfected with sh-PINK1. Measurement data were expressed as mean ± standard deviation. Comparison among multiple groups was conducted by one-way ANOVA with Tukey’s post hoc test. p < 0.05 was indicative of statistical significance. The cell experiment was repeated three times
Fig. 4 PINK1 reduces p53 expression by promoting the phosphorylation of HDAC3. A Binding between HDAC3 and p53 in EGCs verified by Co-IP. B HDAC3 phosphorylation level and protein expression of PINK1, HDAC3, and p53 in EGCs transfected with sh-PINK1 determined by Western blot analysis. C Interaction among PINK1, HDAC3, and p53 in EGCs transfected with sh-PINK1 identified by Co-IP. D Western blot analysis for determination of protein expression of HDAC3 and p53 in EGCs with RGFP966 treatment. E The acetylation level of p53 assessed by Co-IP. F Binding between HDAC3 and PINK1 in EGCs verified by Co-IP. G HDAC3 phosphorylation level and protein expression of PINK1, HDAC3, and p53 in EGCs transfected with sh-PINK1 measured through Western blot analysis. *p < 0.05 vs. EGCs transfected with sh-NC, EGCs treated with 50 ng/mL of TNF-α and 100 ng/mL of IFN-γ) or TNF-α and IFN-γ -exposed EGCs transfected with sh-PINK1. Measurement data were expressed as mean ± standard deviation. Comparison among multiple groups was conducted by one-way ANOVA with Tukey’s post hoc test. p < 0.05 was indicative of statistical significance. The cell experiment was repeated three timesCC BY · PubMed Central
Fig. 5 PINK1 suppresses mitochondrial damage and cell apoptosis of TNF-α- and IFN-γ-stimulated EGCs via inhibition of p53. A Examination of MMP changes in EGCs. B The apoptosis of EGCs detected by flow cytometry. C Protein expression of PINK1, Bax, Bcl-2, Atg5, p62, p53, caspase-3, and cleaved caspase-3 along with LC3-II/I ratio in the EGCs determined by Western blot analysis. *p < 0.05 vs. EGCs treated with 50 ng/mL of TNF-α and 100 ng/mL of IFN-γ following with sh-NC transfection; #p < 0.05 vs. EGCs treated with 50 ng/mL of TNF-α and 100 ng/mL of IFN-γ following with sh-PINK1 transfection. Measurement data were expressed as mean ± standard deviation. Comparison among multiple groups was conducted by one-way ANOVA with Tukey’s post hoc test. The cell experiment was repeated three times. PFT-α, pifithrin-α
Fig. 5 PINK1 suppresses mitochondrial damage and cell apoptosis of TNF-α- and IFN-γ-stimulated EGCs via inhibition of p53. A Examination of MMP changes in EGCs. B The apoptosis of EGCs detected by flow cytometry. C Protein expression of PINK1, Bax, Bcl-2, Atg5, p62, p53, caspase-3, and cleaved caspase-3 along with LC3-II/I ratio in the EGCs determined by Western blot analysis. *p < 0.05 vs. EGCs treated with 50 ng/mL of TNF-α and 100 ng/mL of IFN-γ following with sh-NC transfection; #p < 0.05 vs. EGCs treated with 50 ng/mL of TNF-α and 100 ng/mL of IFN-γ following with sh-PINK1 transfection. Measurement data were expressed as mean ± standard deviation. Comparison among multiple groups was conducted by one-way ANOVA with Tukey’s post hoc test. The cell experiment was repeated three times. PFT-α, pifithrin-αCC BY · PubMed Central
Fig. 6 Dex ameliorates TNF-α- and IFN-γ-stimulated mitochondrial damage and apoptosis in EGCs by the SIRT3-mediated PINK1/HDAC3/p53 pathway. A Examination of MMP changes in EGCs. B The apoptosis of EGCs assessed by flow cytometry. C Western blot analysis for measurement of protein expression of SIRT3, PINK1, Bax, Bcl-2, Atg5, p62, p53, caspase-3, and cleaved caspase-3 along with LC3-II/I ratio in the EGCs. D Apoptosis of EGCs was detected by Hoechst33342 staining and observed in a fluorescence microscope. *p < 0.05 vs. EGCs treated with 50 ng/mL of TNF-α and 100 ng/mL of IFN-γ; #p < 0.05 vs. EGCs treated with 50 ng/mL of TNF-α, 100 ng/mL of IFN-γ and 1 μM of Dex. Measurement data were expressed as mean ± standard deviation. Comparison among multiple groups was conducted by one-way ANOVA with Tukey’s post hoc test. The cell experiment was repeated three times
Fig. 6 Dex ameliorates TNF-α- and IFN-γ-stimulated mitochondrial damage and apoptosis in EGCs by the SIRT3-mediated PINK1/HDAC3/p53 pathway. A Examination of MMP changes in EGCs. B The apoptosis of EGCs assessed by flow cytometry. C Western blot analysis for measurement of protein expression of SIRT3, PINK1, Bax, Bcl-2, Atg5, p62, p53, caspase-3, and cleaved caspase-3 along with LC3-II/I ratio in the EGCs. D Apoptosis of EGCs was detected by Hoechst33342 staining and observed in a fluorescence microscope. *p < 0.05 vs. EGCs treated with 50 ng/mL of TNF-α and 100 ng/mL of IFN-γ; #p < 0.05 vs. EGCs treated with 50 ng/mL of TNF-α, 100 ng/mL of IFN-γ and 1 μM of Dex. Measurement data were expressed as mean ± standard deviation. Comparison among multiple groups was conducted by one-way ANOVA with Tukey’s post hoc test. The cell experiment was repeated three timesCC BY · PubMed Central
Fig. 7 Dex ameliorates intestinal I/R injury in rats through the SIRT3-mediated PINK1/HDAC3/p53 pathway. A Intestinal histopathological changes in rats. B Intestinal damage assessed by Chiu’s score. C Intestinal W/D ratio. D Level of MDA in intestinal tissues of rats. E SOD activity in intestinal tissues of rats. F Serum expression of TNF-α in rat tissues. G Serum expression of IL-6 in rat tissues. H The positive expression of GFAP and S-100β in the intestinal tissue of rats evaluated by IHC. I Western blot analysis for measurement of HDAC3 phosphorylation level and protein expression of GFAP, S-100β, SIRT3, PINK1, Bax, Bcl-2, Atg5, p62, p53, HDAC3, caspase-3, and cleaved caspase-3 as well as LC3-II/I ratio in intestinal tissues of rats. J The apoptosis of EGCs in intestinal tissues of rats examined by TUNEL. *p < 0.05 vs. sham-operated rats; #p < 0.05 vs. I/R-exposed rats; &p < 0.05 vs. I/R-exposed rats with Dex treatment. Measurement data were expressed as mean ± standard deviation. Comparison among multiple groups was conducted by one-way ANOVA with Tukey’s post hoc test. N = 10
Fig. 7 Dex ameliorates intestinal I/R injury in rats through the SIRT3-mediated PINK1/HDAC3/p53 pathway. A Intestinal histopathological changes in rats. B Intestinal damage assessed by Chiu’s score. C Intestinal W/D ratio. D Level of MDA in intestinal tissues of rats. E SOD activity in intestinal tissues of rats. F Serum expression of TNF-α in rat tissues. G Serum expression of IL-6 in rat tissues. H The positive expression of GFAP and S-100β in the intestinal tissue of rats evaluated by IHC. I Western blot analysis for measurement of HDAC3 phosphorylation level and protein expression of GFAP, S-100β, SIRT3, PINK1, Bax, Bcl-2, Atg5, p62, p53, HDAC3, caspase-3, and cleaved caspase-3 as well as LC3-II/I ratio in intestinal tissues of rats. J The apoptosis of EGCs in intestinal tissues of rats examined by TUNEL. *p < 0.05 vs. sham-operated rats; #p < 0.05 vs. I/R-exposed rats; &p < 0.05 vs. I/R-exposed rats with Dex treatment. Measurement data were expressed as mean ± standard deviation. Comparison among multiple groups was conducted by one-way ANOVA with Tukey’s post hoc test. N = 10CC BY · PubMed Central
Fig. 8 A graphic illustration of pathway representing that Dex prevents EGCs from mitochondrial damage and apoptosis by activating SIRT3-mediated PINK1/HDAC3/p53 pathway, thereby alleviating intestinal I/R injury
Fig. 8 A graphic illustration of pathway representing that Dex prevents EGCs from mitochondrial damage and apoptosis by activating SIRT3-mediated PINK1/HDAC3/p53 pathway, thereby alleviating intestinal I/R injuryCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

3 retracted

Show all 68 references

Cited by

See all 53

Metadata

Authors
Zhang, Q., Liu, X.-M., Hu, Q., Liu, Z.-R., Liu, Z.-Y., Zhang, H.-G., Huang, Y.-L., Chen, Q.-H., Wang, W.-X., & Zhang, X.-K.
Affiliations
First Affiliated Hospital of Nanchang University (CN)
Venue
Journal of Translational Medicine
Published
2021-11-12
Volume
19
Issue
1
Pages
463-463
ISSN
1479-5876 (ISSN-L)
OpenAlex
W3211551958
Cited by
52
References
68
Citations by year
2026: 7 · 2025: 12 · 2024: 15 · 2023: 15 · 2022: 3
FWCI
5.50
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Translational Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Natural Science Foundation of China (No. 81660096)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
  • Health Sciences › Medicine › Surgery › Abdominal vascular conditions and treatments
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
Keywords
dexmedetomidine, intestinal ischemia-reperfusion injury, enteric glial cells, SIRT3, PINK1, HDAC3, p53, mitophagy, apoptosis, perioperative analgesia, mitochondrial damage
MeSH terms
Animals, Ischemia, Mitochondria, Neuroglia, Protein Kinases, Reperfusion Injury, Tumor Suppressor Protein p53, Apoptosis, Dexmedetomidine, Rats, Sirtuin 3

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dexmedetomidine inhibits mitochondria damage and apoptosis of enteric glial cells in experimental intestinal ischemia/reperfusion injury via SIRT3-dependent PINK1/HDAC3/p53 pathway. https://app.cochat.ai/papers/10.1186/s12967-021-03027-6
The paper
Zhang, Q., Liu, X.-M., Hu, Q., Liu, Z.-R., Liu, Z.-Y., Zhang, H.-G., Huang, Y.-L., Chen, Q.-H., Wang, W.-X., & Zhang, X.-K. (2021). Dexmedetomidine inhibits mitochondria damage and apoptosis of enteric glial cells in experimental intestinal ischemia/reperfusion injury via SIRT3-dependent PINK1/HDAC3/p53 pathway. Journal of Translational Medicine. https://doi.org/10.1186/s12967-021-03027-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.